This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease
This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease
There are sort of two paths in the research. Some are following the Amyloid Plaque route still. There was a bit of kerfuffle with some of the evidence in other studies which was the basis of this route: https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease
Once you’re too far down one path of research, you pretty much can’t stop, or you risk your entire career, evidence be damned.
Thanks, that was a good read. It is terrible that some researchers end up committing such scientific fraud. Although I am inclined to blame the involved researchers themselves, ultimately, I believe that inflexible (and insufficient) funding is the real culprit